UNITED HEALTH PRODUCTS, INC.

(UEEC)
Delayed OTC Markets  -  12:03 2022-08-09 pm EDT
0.4100 USD   +12.33%
07/19UNITED HEALTH PRODUCTS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
06/23UNITED HEALTH PRODUCTS, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/16United Health Products Announces Settlement of SEC Investigation
AQ
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
08/03/2022 08/04/2022 08/05/2022 08/08/2022 08/09/2022 Date
0.4198(c) 0.41(c) 0.388(c) 0.365(c) 0.41 Last
56 414 123 921 153 980 215 849 59 764 Volume
+1.73% -2.33% -5.37% -5.93% +12.33% Change
More quotes
Estimated financial data (e) ()
Sales 2020 0,00 M - -
Net income 2020 -15,7 M - -
Net Debt 2020 0,51 M - -
P/E ratio 2020 -14,0x
Yield 2020 -
Sales 2021 0,00 M - -
Net income 2021 -30,5 M - -
Net Debt 2021 0,20 M - -
P/E ratio 2021 -4,36x
Yield 2021 -
Capitalization 84,0 M 84,0 M -
EV / Sales 2020 353 968x
EV / Sales 2021 2 289 665x
Nbr of Employees 4
Free-Float 82,9%
More Financials
Company
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze for the healthcare and wound care sectors. Its gauze product, HemoStyp, is a neutralized, oxidized, regenerated cellulose (NORC) derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. Its hemostatic gauze is a collagen-like natural substance created from chemically treated... 
More about the company
All news about UNITED HEALTH PRODUCTS, INC.
07/19UNITED HEALTH PRODUCTS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits..
AQ
06/23UNITED HEALTH PRODUCTS, INC. : Change in Directors or Principal Officers, Other Events, Fi..
AQ
06/16United Health Products Announces Settlement of SEC Investigation
AQ
06/10UNITED HEALTH PRODUCTS, INC. : Regulation FD Disclosure (form 8-K)
AQ
05/27WALL STREET STOCK EXCHANGE : Wall Street on track to end the week in the green
MS
05/27ANALYST RECOMMENDATIONS : Boston Scientific, Dollar General, Dollar Tree, Macy's, VMWare....
MS
05/18United Health Products Provides Regulatory Update
AQ
05/16United Health Products, Inc. Reports Earnings Results for the First Quarter Ended March..
CI
05/16UNITED HEALTH PRODUCTS, INC. Management's Discussion and Analysis of Financial Conditi..
AQ
04/29UNITED HEALTH PRODUCTS, INC. : Other Events (form 8-K)
AQ
04/27United Health Products Provides Regulatory and Business Update
GL
04/01UNITED HEALTH PRODUCTS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
04/01United Health Products, Inc. Reports Earnings Results for the Full Year Ended December ..
CI
02/25MARKETSCREENER'S WORLD PRESS REVIEW : February 25, 2022
MS
02/24UNITED HEALTH PRODUCTS, INC. : Change in Directors or Principal Officers, Other Events (fo..
AQ
More news
News in other languages on UNITED HEALTH PRODUCTS, INC.
05/16United Health Products, Inc. annonce ses résultats pour le premier trimestre clos le 31..
04/08MÄRKTE USA/Nasdaq-Indizes straucheln weiter - Dow knapp im Plus
04/06MÄRKTE USA/Schwächer - Weiter steigende Zinsen bremsen Aktien aus
04/04MÄRKTE USA/Freundlich - Technikaktien klar favorisiert
04/04MÄRKTE USA/Technikaktien starten durch
More news
Analyst Recommendations on UNITED HEALTH PRODUCTS, INC.
More recommendations
Chart UNITED HEALTH PRODUCTS, INC.
Duration : Period :
United Health Products, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Brian Thom Chairman & Chief Executive Officer
Kristofer Heaton Chief Financial Officer & Vice President
Robert J. Denser Independent Director
John Phillips Vice President-Marketing & Commercial Strategy
Sector and Competitors
1st jan.Capi. (M$)
UNITED HEALTH PRODUCTS, INC.-38.14%84
MASIMO CORPORATION-47.59%8 582
NOVOCURE LIMITED3.41%8 132
SHOCKWAVE MEDICAL, INC.25.13%7 938
PENUMBRA, INC.-41.94%6 407
GETINGE AB-43.74%5 970